Auriculotherapy During Medication Abortion
14. juni 2021 oppdatert av: Carolyn Westhoff, Columbia University
Auriculotherapy as an Adjunct for Pain Management During Medication Abortion: a Randomized, Double-blinded, Three-arm Trial
This randomized trial will evaluate the effect of adding auriculotherapy (i.e.
acupuncture applied to the ear) using either gold beads or Pyonex needles in addition to usual care for the relief of pain and anxiety during medication abortion.
The control group will receive placebo auriculotherapy plus usual care.
Participants will receive the assigned treatment immediately after they receive their initial abortion medication.
The investigators will assess pain and anxiety via text message once daily for four days, and in person at a one-week follow-up visit.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Most women undergoing medication abortion with mifepristone and misoprostol report moderate to severe pain, despite treatment with ibuprofen or opioids.
In 2018 National Academies of Sciences, Engineering and Medicine (NASEM) recommended research to improve pain relief.
Limited data indicate that acupuncture is valuable for dysmenorrhea and for labor pain, conditions in which pain may be similar to that experienced during medication abortion.
This randomized trial will recruit women seeking medication abortion after they have completed their routine clinical assessment and after they have received mifepristone.
This study will evaluate two types of auriculotherapy applied to selected acupoints on the external ear.
The study treatments are acupuncture using Pyonex needles and acupressure using gold pellets; both are applied to the ear using adhesive disks.
A control group will receive the adhesive disks alone.
All participants will receive usual medication abortion care, including taking misoprostol 1-3 days after mifepristone and ibuprofen for pain management.
The investigators will query the participants regarding pain and anxiety.
Follow-up will end at the time of the usual clinical follow-up about one week after mifepristone administration.
Studietype
Intervensjonell
Registrering (Faktiske)
138
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
New York
-
New York, New York, Forente stater, 10032
- Columbia University Medical Center
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Hunn
Beskrivelse
Inclusion Criteria:
- Pregnant up to 10 weeks (70 days) gestation
- Seeking medication abortion with mifepristone and misoprostol
- Initial clinical care completed and mifepristone administered
- English- or Spanish-speaking
- Able to use a mobile phone for follow-up on days 1-4
Exclusion Criteria:
- Not a candidate for medication abortion for any reason
- Allergy to adhesives
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Auriculotherapy with needles (acupuncture) + usual care
A designated trained therapist will perform auriculotherapy with 1mm (Pyonex) needles at five acupoints on each ear (10 points total).
The needles are affixed with a small round adhesive disk.
The needles will stay in place until removal at the 1-week follow-up visit
|
Single-use 1.2mm acupuncture press needles attach to pre-specified acupoints on the participant's ears with adhesive disk/tape.
Andre navn:
|
|
Aktiv komparator: Auriculotherapy with gold beads (acupressure) + usual care
A designated trained therapist will perform auriculotherapy with beads at five acupoints on each ear (10 points total).
The beads are affixed with a small round adhesive disk.
The beads will stay in place until removal at the 1-week follow-up visit.
|
A trained co-investigator will place the beads onto prespecified acupoints of the participant's ears.
An adhesive disk will adhere the beads to the ears.
Andre navn:
|
|
Sham-komparator: Placebo group + usual care
A designated trained therapist will place adhesive disks at five acupoints on each ear (10 points total).
The disks resemble those used with the active treatments.
The disks will stay in place until removal at the 1-week follow-up visit.
|
Single-use adhesive disks without needles or beads.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain VAS Score
Tidsramme: Auriculotherapy is applied on the day of mifepristone. Participants take misoprostol 1-3 days later. Pain scores are recorded following misoprostol at 8pm x 4 days (selecting the highest of the 4 for analysis).
|
Self-assessed maximum pain reported using a 0-100 mm visual analog scale (VAS), where 100 signifies maximum pain.
|
Auriculotherapy is applied on the day of mifepristone. Participants take misoprostol 1-3 days later. Pain scores are recorded following misoprostol at 8pm x 4 days (selecting the highest of the 4 for analysis).
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Anxiety VAS Score
Tidsramme: Auriculotherapy is applied on the day of mifepristone. Participants take misoprostol 1-3 days later. Anxiety scores are recorded following misoprostol at 8pm x 4 days (selecting the highest of 4 for analysis).
|
Self-assessed maximum anxiety reported using a 0-100 mm visual analog scale, where 100 signifies maximum anxiety.
|
Auriculotherapy is applied on the day of mifepristone. Participants take misoprostol 1-3 days later. Anxiety scores are recorded following misoprostol at 8pm x 4 days (selecting the highest of 4 for analysis).
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Carolyn Westhoff, MD, Coumbia University
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Ndubisi C, Danvers A, Gold MA, Morrow L, Westhoff CL. Auricular acupuncture as an adjunct for pain management during first trimester abortion: a randomized, double-blinded, three arm trial. Contraception. 2019 Mar;99(3):143-147. doi: 10.1016/j.contraception.2018.11.016. Epub 2018 Dec 7.
- Westhoff CL, Nelson IS, Suarez-Rodriguez A, Gold MA. Auricular acupressure and acupuncture as adjuncts for pain management during first trimester medication abortion: A randomized three-arm trial. Contraception. 2021 May;103(5):348-355. doi: 10.1016/j.contraception.2020.12.003. Epub 2020 Dec 17.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. april 2019
Primær fullføring (Faktiske)
30. mars 2020
Studiet fullført (Faktiske)
30. mars 2020
Datoer for studieregistrering
Først innsendt
26. mars 2019
Først innsendt som oppfylte QC-kriteriene
1. april 2019
Først lagt ut (Faktiske)
3. april 2019
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
6. juli 2021
Siste oppdatering sendt inn som oppfylte QC-kriteriene
14. juni 2021
Sist bekreftet
1. juni 2021
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- AAAS2520
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
JA
IPD-planbeskrivelse
Absent personal identifiers, we will share pain and anxiety outcome data with researchers carrying out similar trials in order to conduct individual participant data meta-analysis.
IPD-delingstidsramme
Data will be available after acceptance of main study outcome paper for publication.
Tilgangskriterier for IPD-deling
By personal contact with PI
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ICF
- ANALYTIC_CODE
- CSR
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Ja
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .